Probi AB (publ)

SSE:PROB.ST

203 (SEK) • At close February 20, 2024
Bedrijfsnaam Probi AB (publ)
Symbool PROB.ST
Munteenheid SEK
Prijs 203
Beurswaarde 2,313,002,300
Dividendpercentage 0.63%
52-weken bereik 165 - 216
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Ms. Anita Johansen
Website https://www.probi.com

An error occurred while fetching data.

Over Probi AB (publ)

Probi AB (publ) researches, develops, manufactures, markets, and sells probiotics for health, pharmaceutical, and food companies. The company conducts research primarily in the fields of gastrointestinal health, digestive health, immune health, bone health, and iron absorption, as well as children's, women's, and senior health. It provides dietary supplement, and food

Vergelijkbare Aandelen

Sedana Medical AB (publ) logo

Sedana Medical AB (publ)

SEDANA.ST

16.85 SEK

Genovis AB (publ.) logo

Genovis AB (publ.)

GENO.ST

43.5 SEK

Bonesupport Holding AB (publ) logo

Bonesupport Holding AB (publ)

BONEX.ST

189.8 SEK

Bactiguard Holding AB (publ) logo

Bactiguard Holding AB (publ)

BACTI-B.ST

84.4 SEK

Attendo AB (publ) logo

Attendo AB (publ)

ATT.ST

37.8 SEK

Hansa Biopharma AB (publ) logo

Hansa Biopharma AB (publ)

HNSA.ST

32.64 SEK

BioInvent International AB (publ) logo

BioInvent International AB (publ)

BINV.ST

16.58 SEK

Q-linea AB (publ) logo

Q-linea AB (publ)

QLINEA.ST

2.49 SEK

Ambea AB (publ) logo

Ambea AB (publ)

AMBEA.ST

57.2 SEK

Financiële Gegevens

Cijfers zijn in miljoenen (SEK)

Cijfers zijn in miljoenen (SEK)